Study of the Impact of Exposure to Outdoor and Indoor Pollutants in Patients With Asthma
NCT ID: NCT05525169
Last Updated: 2022-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2022-11-15
2025-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bronchial Asthma & Its Exacerbation
NCT06331897
The Use of Home-monitoring and mHealth Systems to Predict Asthma Control and the Occurrence of Asthma Exacerbations
NCT02774772
Asthma Breath Biomarker Assessment
NCT03084016
Causes, Characteristics and Mechanisms of Infective Exacerbations in Subjects With Asthma and Chronic Obstructive Pulmonary Disease (COPD)
NCT00512954
Monitoring Asthma and COPD in Primary Care
NCT00542061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with a confirmed diagnosis of asthma for at least 12 months as defined by the investigator,
* Patient with at least 4 asthma exacerbations in the last year
* Patient sleeping at least 6 nights per week in the same home
Exclusion Criteria
* Patient with a diagnosis of COPD, ABPA or associated pulmonary fibrosis,
* Patient with an asthma exacerbation within 15 days prior to the inclusion visit,
* Patient with known occupational exposure,
* Patient living in a dwelling that does not allow the installation of sensors (inability to connect the sensor to the power supply, no location for the outdoor sensor...)
* Patient who plans to move in the next 6 months,
* Patient with a life expectancy of less than 6 months,
* Patient who has someone living in their household also included in EXAP,
* Patient who lives in an apartment and does not have a balcony or space for the outdoor sensor,
* Pregnant or breastfeeding women,
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François-Xavier Blanc, PU-PH
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nantes
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC22_0115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.